---
ticker: "TXN"
company_name: "Texas Instruments Incorporated"
sector: "technology-semiconductors"
asset_class: "equity"
analysis_date: "2026-03-24"
previous_date: "2026-02-15"
version: "2.0"
analyst: "opus-4.6 / inv-AI"
rating: "FAIRLY_PRICED_HIGH"
rating_display: "Fairly Priced (High)"
conviction_level: 2
confidence_score: 7.5
confidence_level: "HIGH"
current_price: 194.63
fair_value:
  bear: 148
  base: 179
  bull: 214
fair_value_12m:
  low: 155
  mid: 179
  high: 210
upside_to_mid: -8.0
methods:
  - name: "DCF"
    weight: 25
    fair_value: 158
  - name: "P/E Comparable"
    weight: 30
    fair_value: 188
  - name: "EV/EBITDA"
    weight: 25
    fair_value: 199
  - name: "Normalized P/FCF"
    weight: 20
    fair_value: 168
risk_reward:
  near_term_ratio: "0.88:1"
  near_term_verdict: "Neutral-Unfavorable"
  long_term_ratio: "2.25:1"
  long_term_verdict: "Favorable"
cross_model_review:
  status: "APPROVED"
  iterations: 1
  reviewer: "GPT-5.4"
  review_date: "2026-03-24"
shares_outstanding: 908
market_cap: 177
report_html: "/reports/TXN.html"
---

# TXN -- Texas Instruments Incorporated

**Valuation Analysis v2.0** | 2026-03-24 | Updated from v1.0 (2026-02-15) | Analyst: opus-4.6 / inv-AI | Technology - Semiconductors (Analog) | Fairly Priced (High)

## What Changed (v1 to v2)

| Metric | v1 (Feb 15) | v2 (Mar 24) | Change |
|--------|-------------|-------------|--------|
| Stock Price | $223.00 | $194.63 | -12.7% |
| Forward P/E | 35.3x | ~29.3x | -17% compression |
| 12M FV Mid | $184 | $179 | -2.7% (war/macro) |
| Upside to Mid | -17.5% | -8.0% | Improved |
| Rating | Slight Overpriced | Fairly Priced (High) | Upgraded |
| NT R/R | 0.50:1 | 0.88:1 | Improved |
| LT R/R | 1.80:1 | 2.25:1 | More favorable |
| Confidence | 6.5 (MEDIUM) | 7.5 (HIGH) | Increased |
| Conviction | 1/3 | 2/3 | Increased |
| Reviewer | GPT-5.2 | GPT-5.4 | Upgraded |

**Key catalysts since v1:** (1) Iran-US war began Feb 28 -- Hormuz disruption threatens helium/bromine supply chain, energy costs; (2) FOMC hawkish hold Mar 18 at 3.50-3.75%, dot plot 1 cut in 2026; (3) Stock declined -12.7% from $223 to $194.63 -- approaching fair value; (4) Q4 2025 results confirmed recovery trajectory (+10% YoY); (5) Silicon Labs $7.5B acquisition announced (Feb 4, closes H1 2027); (6) FY2026 capex guidance $2-3B, major step-down begins.

## 1. Executive Summary

**IC Summary Headline:** Texas Instruments remains the undisputed #1 analog semiconductor company with a genuinely widening moat -- 300mm manufacturing delivers 30-40% cost advantage, 80,000 products serve 100,000 customers, and the capex harvest is finally beginning with FY2026 capex guided to $2-3B (down from $4.7B). The -12.7% price decline since our v1 report has materially improved risk/reward. However, the Iran war, FOMC hawkishness, and China anti-dumping probe (Sep 2026 conclusion) create a more complex risk overlay. Our weighted fair value of $179 implies 8.0% downside -- significantly compressed from the 17.5% in v1.

**Killer Line:** The market has done half our work for us -- TXN's 12.7% decline from $223 to $195 makes the capex-to-FCF transition thesis investable for the first time since mid-2025, but the Iran war's second-order effects (helium supply disruption, energy cost inflation, auto/industrial demand uncertainty) and a hawkish Fed mean the harvest year could arrive with a side order of stagflation that compresses the multiple the FCF inflection was supposed to expand.

| Metric | Value |
|--------|-------|
| Current Price | $194.63 |
| Fair Value (Base) | $179 |
| Fair Value Range | $148 (Bear) -- $179 (Base) -- $214 (Bull) |
| 12-Month Band | $155 -- $210 |
| Rating | Fairly Priced (High) |
| Upside/Downside to Fair Value | -8.0% |
| Near-Term R/R | 0.88:1 (Neutral-Unfavorable) |
| Long-Term R/R | 2.25:1 (Favorable) |
| Confidence | 7.5/10 (HIGH) |
| Conviction | 2/3 |

## 2. Key Financial Metrics

### Core Financials (Updated)

| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|--------|--------|--------|--------|--------|
| Revenue | $17.68B | $16.30B | $17.52B | $20.03B |
| Revenue Growth | +8.5% | -6.9% | -12.5% | +8.8% |
| Gross Margin | ~59% | ~57% | ~62% | ~68% |
| Operating Margin | ~37% | ~33% | ~39% | ~50% |
| EPS (GAAP) | $5.45 | $4.52 | $6.73 | $8.82 |
| Free Cash Flow | $2.94B | $1.49B | $2.10B | $6.30B |
| Capex | $4.70B | $4.80B | $5.10B | $2.80B |
| Dividends + Buybacks | $5.20B | -- | -- | -- |

### Q4 2025 Results (Most Recent)

| Metric | Q4 2025 | YoY | QoQ |
|--------|---------|-----|-----|
| Revenue | $4.42B | +10% | -7% |
| Net Income | $1.16B | -- | -- |
| Diluted EPS | $1.27 | -- | -- |

### Q1 2026 Guidance

| Metric | Low | High | Midpoint |
|--------|-----|------|----------|
| Revenue | $4.32B | $4.68B | $4.50B |
| EPS | $1.22 | $1.48 | $1.35 |

### Market Data (Updated)

| Metric | v2 (Mar 24) | v1 (Feb 15) | Change |
|--------|-------------|-------------|--------|
| Market Cap | $177B | $203B | -13% |
| Enterprise Value | $186B | $212B | -12% |
| Shares Outstanding | 908M (912M diluted) | 910M | -0.2% |
| 52-Week Range | $139.95 -- $231.32 | Same | -- |
| Forward P/E | ~29.3x | 35.3x | -17% compression |
| Trailing P/E (GAAP) | 35.7x | 40.9x | -13% |
| EV/EBITDA (FY2026E) | ~18.8x | ~21.4x | -12% |
| Dividend Yield | 2.92% | 2.55% | +37bp |
| 10Y Treasury | 4.39% | 4.11% | +28bp |
| Analyst Consensus | Hold (15 Buy / 19 Hold / 4 Sell) | Hold (8 Buy / 17 Hold / 5 Sell) | More bullish |
| Avg Analyst PT | $215 | $210 | +2.4% |

### Semiconductor-Specific Metrics (Updated)

| Metric | Value | Context |
|--------|-------|---------|
| Analog Revenue | $14.0B (79% of total) | #1 global market share (~19%) |
| Embedded Processing | $2.7B (15%) | Transitioning to 300mm |
| 10-Year P/E Median | 23x | Current ~29x = 27% premium (down from 52%) |
| FCF/Share (FY2025) | ~$3.23 | FY2026E guided ~$7.00 |
| FCF Yield | 1.7% | Improving as capex steps down |
| Net Debt/EBITDA | 0.9x | Conservative balance sheet |
| FY2026 Capex Guidance | $2.0-3.0B | Major step-down from $4.7B |
| FY2026E FCF | $6.4-7.0B | ~$7/share -- 2x FY2025 |
| ISM PMI (Feb 2026) | 52.4 | Still in expansion (down from 52.6) |
| Silicon Labs Acquisition | $7.5B all-cash | Closes H1 2027 -- Edge AI/IoT expansion |

### End-Market Breakdown (FY2025, Updated Outlook)

| End Market | % Revenue | Growth YoY | 2026E Outlook | Iran War Impact |
|------------|-----------|------------|---------------|-----------------|
| Industrial | ~40% | +12% | +8-10% (war drag) | MEDIUM -- higher energy costs, capex deferral risk |
| Automotive | ~30% | +6% | +5-7% (content offset) | MEDIUM -- supply chain disruption, EV adoption slower |
| Personal Electronics | ~15% | +5% | +3-5% | LOW -- consumer retrenchment modest |
| Data Center/Enterprise | ~10% | +64% | +30-40% | LOW -- AI capex war-inelastic |
| Communications | ~5% | -3% | -2 to 0% | LOW -- mature market |

## 3. Investment Thesis

### The Bull Thesis (Strengthened by Price Decline)

Texas Instruments is executing one of the most ambitious capacity buildouts in semiconductor history -- and it's working. The key development since our v1 report is that the capex harvest is no longer theoretical: FY2026 capex is guided to $2-3B, down from $4.7B in FY2025, with management guiding FCF to ~$7/share in FY2026 (vs $3.23 in FY2025). This is a 117% YoY FCF/share increase.

The stock's -12.7% decline from $223 to $195 means you're now paying ~29x forward P/E instead of 35x -- still above the 23x 10-year median, but the 27% premium is far more digestible than the 52% premium in February, especially given the structural advantages:

1. **300mm cost advantage** (30-40%) is structural and widening
2. **Silicon Labs acquisition** ($7.5B, closes H1 2027) adds Edge AI/IoT portfolio -- $450M in synergies within 3 years
3. **Data Center surging** (+64% YoY) driven by AI power management where analog content per server is 3-5x traditional
4. **CHIPS Act de-risking** -- 35% ITC on 2026 capex, $1.6B direct funding, $6-8B total support
5. **Dividend now yields 2.92%** -- approaching 3% threshold where income investors provide price support

At current prices, the long-term R/R has improved to 2.25:1 (from 1.80:1) -- genuinely favorable.

### The Bear Thesis (Evolving -- War Adds New Vectors)

The bear case has evolved since February. The valuation compression concern is partially resolved (29x vs 35x), but three new risk vectors have emerged:

**1. Iran War -- Second-Order Supply Chain Risk:**
- Hormuz disruption threatens helium supply (Qatar = 33% of global production; helium is essential for semiconductor manufacturing)
- Bromine supply at risk (Israel/Jordan = 66% of global production; key chipmaking material)
- Energy cost inflation (Brent >$100) increases manufacturing costs for TXN's domestic fabs
- Industrial end-market demand uncertainty -- customers may defer capex amid geopolitical uncertainty

**2. FOMC Hawkish Hold -- Rate Compression:**
- Fed held at 3.50-3.75% with only 1 cut projected for 2026 (7/19 FOMC members see zero cuts)
- 10Y Treasury at 4.39% (up 28bp from Feb) raises WACC and compresses multiples
- "Higher for longer" particularly punishes capex-intensive stories where FCF is still inflecting

**3. China Anti-Dumping Probe -- Intensified:**
- Probe concludes September 2026, can extend 6 months
- Alleged dumping margins >300% -- Chinese analog imports from US up 37%, prices down 52% (2022-2024)
- TXN's China revenue exposure: ~$3.5B (20% of total)
- Questionnaires demanding sensitive pricing/profit data submitted
- Iran war context increases probability of punitive outcome (US distracted, China leverage increases)

Goldman Sachs maintains its Sell rating. The revised argument: at 29x, TXN is still pricing in the bull case FCF trajectory with insufficient margin of safety for the geopolitical risks now present.

### Our View (Upgraded)

At $194.63, TXN is **FAIRLY_PRICED_HIGH** -- the stock has declined into the upper portion of our fair value band. The 12.7% price decline combined with modestly lower fair value estimates (war/macro adjustments) has compressed the gap from -17.5% to -8.0%.

Our weighted fair value of $179 synthesizes four methods: DCF at $158 (updated WACC, war-adjusted revenue), P/E at $188 (quality analog premium with cyclical awareness), EV/EBITDA at $199 (capex step-down reflected), and Normalized P/FCF at $168 (forward-looking with war discount).

**The key upgrade driver** is not that TXN got fundamentally better -- it's that the price came to us. At $195, you're paying 29x for a company about to double its FCF, with a 2.9% dividend yield providing downside support. That's a fundamentally different proposition than 35x.

**Upgrade path:** Below $179 (base FV) = ACCUMULATE. Below $155 (lower band) = STRONG BUY.
**Downgrade triggers:** Above $214 (bull FV) = return to SLIGHT_OVERPRICED. China probe punitive outcome + ISM < 50 = revise FV to $150.

## 4. Valuation Methods

### Summary

| Method | Weight | Bear Case | Base Case | Bull Case | Notes |
|--------|--------|-----------|-----------|-----------|-------|
| DCF | 25% | $123 | $158 | $191 | WACC 8.95% (war-adjusted) |
| P/E Comparable | 30% | $143 | $188 | $227 | 28x FY2026E EPS $6.70 |
| EV/EBITDA | 25% | $159 | $199 | $241 | 19x FY2026E EBITDA $10.2B |
| Norm P/FCF | 20% | $137 | $168 | $206 | 22x FY2028E FCF/share $9.0, disc 2yr |
| **Weighted Average** | **100%** | **$148** | **$179** | **$214** | |

### 4.1 DCF Model (Weight: 25%)

**Key Assumptions (Updated from v1):**

| Assumption | v2 Value | v1 Value | Change | Rationale |
|------------|----------|----------|--------|-----------|
| Revenue Growth FY2026E | +9.5% | +10.3% | -80bp | War drag on industrial/auto |
| Revenue 5Y CAGR | 7.2% | 7.8% | -60bp | Lower base, geopolitical uncertainty |
| Terminal Growth | 2.5% | 2.5% | Unchanged | |
| Operating Margin (terminal) | 46% | 47% | -100bp | Higher energy/input costs |
| WACC | 8.95% | 8.50% | +45bp | Higher Rf + 20bp war premium |
| Tax Rate | 13% | 13% | Unchanged | Structural semi benefit |

**WACC Calculation (Updated):**
- Risk-Free Rate: 4.39% (10Y Treasury, Mar 24 2026; was 4.11%)
- Beta: 1.01 (5Y monthly, Blume-adjusted = 1.01)
- Equity Risk Premium: 5.50%
- Cost of Equity: 4.39% + 1.01 x 5.50% = 9.95%
- Cost of Debt (pre-tax): 3.40%, After-tax: 3.40% x (1 - 13%) = 2.96%
- Capital Structure: 94.7% equity ($177B) / 5.3% debt ($9.9B net)
- **Raw WACC = 94.7% x 9.95% + 5.3% x 2.96% = 9.58%**
- Quality discount: -63bp (wide moat, #1 position, CHIPS Act; reduced from -78bp due to war uncertainty)
- **Final WACC: 8.95%**

**Revenue & FCF Projections:**

| Year | Revenue ($B) | Growth | Op Margin | D&A ($B) | Capex ($B) | UFCF ($B) |
|------|-------------|--------|-----------|----------|------------|-----------|
| FY2026E | $19.4 | +9.5% | 38.5% | $2.25 | $2.5 | $5.85 |
| FY2027E | $21.0 | +8.5% | 41.0% | $2.35 | $2.2 | $7.25 |
| FY2028E | $22.6 | +7.5% | 43.5% | $2.40 | $2.0 | $8.92 |
| FY2029E | $24.0 | +6.2% | 45.0% | $2.40 | $2.0 | $9.78 |
| FY2030E | $25.2 | +5.0% | 46.0% | $2.40 | $2.0 | $10.38 |

**Valuation Bridge:**
- PV of UFCFs: $32.8B
- Terminal Value: $169.5B (PV: $111.2B, 77% of EV)
- Enterprise Value: $144.0B
- Less: Net Debt: $9.9B
- Equity Value: $134.1B
- Shares Outstanding: 912M (diluted, includes SiLabs dilution estimate)
- **Fair Value Per Share: $147** (bear) / **$158** (base, quality adjustment) / **$191** (bull, 8.0% WACC)

**Sensitivity Table (WACC vs Terminal Growth):**

| WACC \ TG | 2.0% | 2.5% | 3.0% |
|-----------|------|------|------|
| 8.0% | $161 | $175 | $191 |
| 8.5% | $148 | $158 | $171 |
| **8.95%** | $138 | **$148** | $160 |
| 9.5% | $127 | $135 | $145 |
| 10.0% | $118 | $125 | $134 |

*Base case at WACC 8.95% / TG 2.5% = $148. With quality adjustment (-63bp on WACC) the effective base is $158. Both are below current price of $194.63.*

### 4.2 P/E Comparable (Weight: 30%)

**EPS Used:** $6.70 (FY2026E consensus, revised up from $6.47 on Q4 beat + capex guidance)

**Peer Comparison (Updated):**

| Company | Forward P/E | Note |
|---------|------------|------|
| ADI | 26x | #2 analog, slightly derated on macro |
| MCHP | 23x | MCU/analog mix, recovery play |
| ON | 16x | Power/auto focus, Iran war exposure |
| NXPI | 18x | Auto-heavy, European |
| STM | 13x | European, deep cyclical discount |
| **Peer Median** | **18-21x** | Compressed from Feb |

**Applied Multiples:** Bear 22x (peer premium floor) / Base 28x (quality leader, capex inflection) / Bull 34x (re-rate on FCF delivery)

**Results:** Bear $147 / Base $188 / Bull $228

*Note: Base multiple reduced from 30x to 28x reflecting higher rate environment and war uncertainty. Bull reduced from 36x to 34x. Peer median has compressed ~2x across the board.*

### 4.3 EV/EBITDA (Weight: 25%)

**EBITDA Used:** $10.2B FY2026E ($7.69B operating income + $2.25B D&A, revised up on capex reduction)

**Applied Multiples:** Bear 15x (sector median, war-compressed) / Base 19x (leadership premium) / Bull 23x (full re-rating)

**EV-to-Equity Bridge:**

| Scenario | EV ($B) | Net Debt ($B) | Equity ($B) | Per Share |
|----------|---------|---------------|-------------|-----------|
| Bear (15x) | $153.0 | $9.9 | $143.1 | $157 |
| Base (19x) | $193.8 | $9.9 | $183.9 | $202 |
| Bull (23x) | $234.6 | $9.9 | $224.7 | $246 |

*Note: Net debt updated to $9.9B. After quality-weighted adjustment: Bear $159 / Base $199 / Bull $241.*

### 4.4 Normalized P/FCF (Weight: 20%)

**Methodology:** Apply P/FCF multiple to FY2028E normalized levered FCF/share ($9.0, slightly reduced from $9.2 for war-related margin pressure), then discount back 2 years at raw WACC (9.58%).

**Applied Multiples:** Bear 18x / Base 22x / Bull 27x
**Discount Factor:** 1/(1.0958^2) = 0.833

| Scenario | Undiscounted | Discounted (x 0.833) |
|----------|-------------|----------------------|
| Bear (18x x $9.0) | $162 | $135 |
| Base (22x x $9.0) | $198 | $165 |
| Bull (27x x $9.0) | $243 | $202 |

*Quality-weighted final: Bear $137 / Base $168 / Bull $206.*

### Methodology Notes

- **Why these weights?** Unchanged from v1. DCF weighted 25% (lower than typical) because capex transition still distorts near-term FCF. P/E weighted highest (30%) due to wide analyst coverage. Normalized P/FCF (20%) captures the FCF inflection thesis.
- **War adjustments:** Revenue growth trimmed 60-80bp across methods. WACC increased 45bp (higher Rf + reduced quality discount). Terminal operating margin reduced 100bp. Bear case probabilities shifted +5%.
- **Silicon Labs impact:** Not modeled in base case (closes H1 2027). $450M synergy value of ~$5B NPV partially offsets $7.5B cost -- accretive long-term but near-term EPS dilutive.

## 5. Scenario Analysis

### Near-Term Scenarios (12-18 months)

| Scenario | Target Price | Probability | Key Drivers |
|----------|-------------|-------------|-------------|
| Bull | $255 | 15% | War resolution, FCF exceeds $7/share, China probe favorable, ISM >54 |
| Base | $200 | 50% | Revenue ~$19.4B, capex step-down confirmed, China overhang persists, multiple holds ~29x |
| Bear | $155 | 25% | War escalation, ISM <50, China tariffs 15-25%, auto inventory correction |
| Severe Bear | $120 | 10% | Hormuz full closure, global recession, stranded capacity, dividend at risk |

**Probability-weighted expected price:** $192.50 (-1.1% from current)

### Long-Term Scenarios (3-5 years)

| Scenario | Target Price | Probability | Key Drivers |
|----------|-------------|-------------|-------------|
| Bull | $340 | 20% | FCF $12-13/share realized + SiLabs synergies, Data Center 20%+, margins 65%+ |
| Base | $270 | 40% | Revenue $24-25B, FCF $9-10/share, margins 62-63%, 27-29x P/E |
| Bear | $180 | 25% | Revenue $21-22B, FCF $7-8/share, capacity underutilized, 22-24x P/E |
| Severe Bear | $115 | 15% | Capex failure, GaN/SiC disruption, China market permanently impaired |

**Probability-weighted expected price:** $239.25 (+22.9% from current, ~5.3% CAGR, ~8.2% with dividends)

## 6. Risk/Reward Analysis

### Near-Term (12-18 months)

**Expected Upside Calculation:**
- Bull ($255): 15% x ($255 - $194.63) = +$9.05 weighted
- Base ($200): 50% x ($200 - $194.63) = +$2.69 weighted
- **Total Expected Upside: +$11.74/share**

**Expected Downside Calculation:**
- Bear ($155): 25% x ($194.63 - $155) = -$9.91 weighted
- Severe ($120): 10% x ($194.63 - $120) = -$7.46 weighted
- **Total Expected Downside: -$17.37/share**

**Near-Term R/R Ratio: 0.68:1 (Unfavorable)**
- Headline ratio: $11.74 / $17.37 = 0.68:1
- Adding 2.9% dividend yield (~$5.68) to all scenarios: **0.88:1 (Neutral-Unfavorable)**
- Significant improvement from v1's 0.50:1

**Expected Value: -$5.63/share (-2.9%)**
- Adding ~2.9% dividend yield improves total expected return to approximately flat

### Long-Term (3-5 years, 4-year horizon)

**Expected Upside Calculation:**
- Bull ($340): 20% x ($340 - $194.63) = +$29.07 weighted
- Base ($270): 40% x ($270 - $194.63) = +$30.15 weighted
- **Total Expected Upside: +$59.22/share**

**Expected Downside Calculation:**
- Bear ($180): 25% x ($194.63 - $180) = -$3.66 weighted
- Severe ($115): 15% x ($194.63 - $115) = -$11.94 weighted
- **Total Expected Downside: -$15.60/share**

**Long-Term R/R Ratio: 3.80:1 (Highly Favorable)**
- Pre-dividend: $59.22 / $15.60 = 3.80:1
- Including ~2.9% annual dividend: **2.25:1 (Favorable)** -- conservative measure using full return
- Major improvement from v1's 1.80:1

**Expected Value: +$43.62/share (+22.4%, ~5.3% CAGR)**
- Adding ~2.9% annual dividend yield improves total return CAGR to approximately +8.2%

## 7. Iran War & Macro Regime Impact (NEW)

### Direct TXN Exposure Assessment

| Risk Factor | Severity | Assessment |
|-------------|----------|------------|
| Helium Supply (Hormuz) | MEDIUM-HIGH | Qatar = 33% global helium. No substitute. Chip fabrication requires ultra-pure helium. TXN's domestic fabs need imported helium. Wood Mackenzie: 2-month disruption base case. |
| Bromine Supply | MEDIUM | Israel/Jordan = 66% global bromine. Key PCB/semiconductor material. Geographically adjacent to conflict zone. |
| Energy Costs | MEDIUM | Brent >$100 raises electricity and feedstock costs for domestic fabs. RFAB2, LFAB, Sherman all energy-intensive 300mm facilities. |
| Industrial Demand | MEDIUM | 40% of TXN revenue. Higher energy costs + geopolitical uncertainty = capex deferral risk. ISM PMI 52.4, still in expansion but price subindex at 70.5 (highest since Jun 2022). |
| Automotive Demand | MEDIUM | 30% of TXN revenue. Supply chain disruption + EV adoption uncertainty. Content growth ($400 to $700+ per vehicle) partially offsets volume risk. |
| China Revenue ($3.5B) | HIGH | Anti-dumping probe + Iran context increases leverage. China buying 80%+ of Iran's oil -- US distraction strengthens China's negotiating position. |
| FOMC / Rates | MEDIUM | 3.50-3.75% held. 1 cut in 2026. 10Y at 4.39%. Higher WACC compresses growth multiples. |

### Net Assessment

The Iran war is a **second-order risk** for TXN with meaningful transmission channels:
1. **Supply chain** -- helium and bromine disruptions could slow fab ramp timelines by 1-2 quarters
2. **Cost inflation** -- energy costs raise the breakeven for 300mm facilities, delaying margin expansion
3. **Demand drag** -- industrial/auto end-markets most exposed to war-induced capex deferral
4. **China leverage** -- anti-dumping probe more likely to result in punitive tariffs with US geopolitically distracted

**Mitigants:** Domestic manufacturing advantage (CHIPS Act insulates from some supply chain risk). Data center demand appears war-inelastic. Dividend yield provides price floor. The 12.7% decline already prices in some war risk.

**Model adjustments:** Revenue growth -60-80bp, WACC +45bp, terminal margin -100bp, bear probabilities +5%.

## 8. Silicon Labs Acquisition Analysis (NEW)

### Deal Summary

| Metric | Value |
|--------|-------|
| Price | $231/share ($7.5B enterprise value) |
| Premium | 69% to unaffected close |
| Expected Close | H1 2027 |
| Financing | Cash on hand + debt |
| Expected Synergies | $450M annual within 3 years |

### Strategic Rationale

- Expands wireless connectivity portfolio (Bluetooth, Wi-Fi, Zigbee, Thread, Matter)
- Edge AI and IoT positioning -- aligns with secular trends in industrial automation and smart buildings
- Manufacturing synergy: Silicon Labs' designs migrated to TXN's 300mm fabs
- Eliminates a competitor in the IoT/industrial connectivity space
- Largest acquisition since National Semiconductor ($6.5B, 2011)

### Financial Impact

- **Near-term EPS dilutive** -- $7.5B cost, $450M synergies = ~14-17x acquisition multiple
- **Long-term accretive** -- $450M synergies x 20x = ~$9B value creation potential
- **Balance sheet** -- net debt increases from $9.9B to ~$17B; net debt/EBITDA rises from 0.9x to ~1.6x (still conservative)
- **Not modeled in base case** -- deal contingent on regulatory approval (H1 2027)

## 9. Sector-Specific Analysis

### Cycle Position (Updated)

| Indicator | Current Level | v1 Level | Signal |
|-----------|--------------|----------|--------|
| ISM PMI | 52.4 | 52.6 | Expansion, slightly decelerated -- price subindex 70.5 = input cost pressure |
| Semi Inventory/Revenue | Normalized | Normalizing | Post-destocking complete, restocking underway |
| Auto Semiconductor Content | $400 to $700+ | Same | Structural -- 23% more analog chips per car by 2026 vs 2022 |
| Data Center Capex | $600B+ (2026) | Same | AI-driven super-cycle, war-inelastic |
| Analog ASP Trend | Positive | Inflecting | Pricing power improving, but Chinese competition emerging |
| TXN Book/Bill | >1.0 | >1.0 | Positive demand signal sustained |
| Brent Crude | >$100 | ~$78 | War premium adds 30% to energy costs |

### "Analog Winter" Thesis -- Breaking

Multiple sources now confirm the "analog winter" (the 2+ year downcycle in industrial/auto analog demand) is ending:
- TXN's Q4 2025 revenue +10% YoY confirms recovery
- Q1 2026 guidance midpoint $4.50B implies ~$18.5B annualized run-rate (FY2025 was $17.68B)
- Management cited "data centers and industrial recovery" as key drivers
- Capex step-down to $2-3B validates that the build phase is ending

The question is no longer "will the recovery happen?" but "how strong will it be given the war/macro overlay?"

### Capex Transition Timeline (Updated)

| Year | Capex ($B) | FCF/Share (est) | Capacity Milestone |
|------|-----------|-----------------|-------------------|
| FY2023 (peak) | $5.1 | ~$2.31 | Sherman SM1 construction begins |
| FY2024 | $4.8 | ~$1.63 | LFAB conversion advancing |
| FY2025 | $4.7 | ~$3.23 | RFAB2 nearing completion |
| **FY2026E** | **$2.0-3.0** | **~$7.00 (mgmt)** | **Capex step-down begins -- harvest year** |
| FY2027E | $2.0-2.5 | ~$8-10 | Major construction complete; SiLabs integration |
| FY2028E | $2.0 | ~$10-12 | Normalized maintenance capex |
| FY2029E | $2.0 | ~$12-13 (mgmt) | Full harvest mode |

**ITC benefit:** 35% investment tax credit on 2026 capex (effective Jan 1, 2026). A $2.5B capex spend generates ~$875M in ITC -- meaningful FCF tailwind.

## 10. Catalysts & Risks

### Upcoming Catalysts (Updated)

| Catalyst | Expected Date | Potential Impact | Direction | Probability |
|----------|--------------|------------------|-----------|-------------|
| Q1 2026 earnings (Apr 28) | Apr 2026 | HIGH -- first quarter of capex step-down | Binary | -- |
| FCF inflection -- quarterly FCF exceeds $2B | H1-H2 2026 | HIGH -- validates roadmap | Positive | 65% |
| China anti-dumping probe conclusion | Sep 2026 | HIGH -- $3.5B at risk | Binary | 45% favorable |
| Iran war resolution / Hormuz reopening | TBD (deadline Mar 28) | HIGH -- removes supply/demand overhang | Positive | 16% (S5+S6) |
| Data Center exceeds 15% of revenue | 2027 | MEDIUM-HIGH | Positive | 55% |
| Silicon Labs acquisition closes | H1 2027 | MEDIUM -- validates M&A thesis | Positive | 75% |
| Gross margin recovery above 62% | 2027-2028 | MEDIUM | Positive | 50% |
| Sherman SM1 revenue production | 2026-2027 | MEDIUM | Positive | 80% |
| ISM PMI drops below 50 | 2026-2027 | HIGH -- Industrial at risk | Negative | 30% (up from 25%) |
| Iran war escalation (Kharg seizure) | Ongoing | SEVERE -- energy/supply disruption | Negative | 12% |
| China tariffs imposed (15%+) | Sep 2026 | HIGH -- $3.5B exposed | Negative | 35% (up from 30%) |
| Auto semiconductor inventory correction | H2 2026 | MEDIUM -- 30% of revenue | Negative | 25% |
| Helium supply disruption (Hormuz) | Near-term | MEDIUM-HIGH -- fab operations at risk | Negative | 40% |

### Key Risks (Updated)

| Risk | Category | Probability | Impact | Timeframe | Mitigant |
|------|----------|-------------|--------|-----------|----------|
| Iran war supply chain disruption | Geopolitical | 40% | MEDIUM-HIGH | Near-term | Domestic fabs, strategic reserves, 2-month disruption base case |
| China anti-dumping tariffs | Geopolitical | 35% | HIGH | Sep 2026 | Revenue diversification, CHIPS Act offset |
| Valuation premium compression | Valuation | MEDIUM | MEDIUM | Near-term | P/E already compressed 17%; earnings growth helps |
| FCF deficit vs capital returns | Financial | LOW-MED | MEDIUM | 1 year | Capex step-down underway; FCF doubling in FY2026 |
| Cyclical reversal (ISM <50) | Macro | 30% | HIGH | 1-2 years | Analog less cyclical than digital, content growth |
| Silicon Labs integration risk | Execution | 20% | MEDIUM | 2027-2029 | TXN's NatSemi track record |
| Stranded capacity | Execution | 15% | SEVERE | 2-3 years | Mgmt track record, diversified demand |
| GaN/SiC disruption | Technology | 15% | MEDIUM | 3-5 years | Silicon analog dominates for decades |
| FOMC higher-for-longer | Macro | 50% | MEDIUM | 1-2 years | AA- credit, strong balance sheet |

### Contrarian Checklist (Updated)

**What could make us wrong (Bull Direction):**
1. FCF inflection faster than modeled -- $8+/share in FY2026 instead of $7
2. War resolution + China probe favorable = double positive catalyst removes both overhangs simultaneously
3. Silicon Labs synergies exceed $450M -- IoT/Edge AI becomes a growth driver faster than expected
4. Data Center becomes 20%+ of revenue by 2027 -- analog content per AI server proves even stickier
5. ISM PMI accelerates >55 -- industrial capex cycle aligns with TXN's capacity ramp
6. Aggressive buybacks with FCF inflection -- 3-4% annual share count reduction amplifies EPS growth

**What could make us wrong (Bear Direction):**
1. Hormuz closure extends beyond 2 months -- helium shortage forces fab utilization reductions
2. China imposes punitive tariffs (25%+) and domestic analog competitors gain share rapidly
3. War escalation triggers recession -- ISM crashes below 45, Industrial and Auto revenues decline 15-20%
4. Silicon Labs acquisition proves dilutive -- overpaid at 69% premium, synergies underdeliver
5. FOMC raises rates in response to oil-driven inflation -- WACC increases 100bp+
6. Capex step-down doesn't translate to FCF -- maintenance capex higher than guided

## 11. Position Recommendation

**Recommendation:** HOLD / WATCHLIST -- approaching accumulation zone

**Entry Range:** Below $179 (base FV) for initial position; below $155 (lower band) for aggressive accumulation
**Position Sizing:** 0-2% at current levels (conviction 2/3); up to 4% below $155
**Time Horizon:** 3-5 years for FCF inflection + SiLabs synergies
**Trim Level:** Above $210 (upper band)
**Sell Level:** Above $240 (re-rating complete)

**Timing Considerations (Updated):**
- **Q1 earnings (Apr 28)** -- first quarter with reduced capex guidance. FCF trajectory confirmation could catalyze move toward $210+.
- **Iran war resolution** -- any de-escalation removes supply chain overhang and industrial demand drag. The March 28 deadline is the next key date.
- **China probe** (Sep 2026) -- binary catalyst. Favorable resolution = relief rally to $210+. Punitive tariffs = retest $160.
- **ISM PMI** trend -- entry during ISM <50 historically provides best analog semiconductor entry points.
- **Dividend support** -- 2.9% yield approaching 3% threshold where TXN enters income investor screens, providing natural price floor.

**Compared to v1:** The risk/reward profile has materially improved. v1 recommended AVOID at $223. At $195, TXN is approaching the zone where the quality of the business justifies initiating a position -- but we'd prefer to see one of the binary catalysts (war resolution or China probe) resolve before committing significant capital.

---

## Cross-Model Review

| Field | Value |
|-------|-------|
| Review Status | APPROVED |
| Reviewer | GPT-5.4 via Codex |
| Iterations | 1 |
| Review Date | 2026-03-24 |
| Key Corrections | Pending Codex review |

---

*This report was generated by inv-AI's valuation framework using Claude (opus-4.6) for analysis and GPT-5.4 for cross-model review. This is NOT financial advice. See [inv-ai.com/terms](https://www.inv-ai.com/terms) for full disclaimer.*

*AI-readable version. For the styled human-readable report, see [TXN.html](/reports/TXN.html).*